TORONTO and HAIFA, Israel, March 22, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (NRX:CA) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results